These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17691956)

  • 1. The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development.
    Guazzi M; Samaja M
    Curr Med Chem; 2007; 14(20):2181-91. PubMed ID: 17691956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.
    Shimizu-Albergine M; Rybalkin SD; Rybalkina IG; Feil R; Wolfsgruber W; Hofmann F; Beavo JA
    J Neurosci; 2003 Jul; 23(16):6452-9. PubMed ID: 12878685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach.
    Gratzke C; Uckert S; Kedia G; Reich O; Schlenker B; Seitz M; Becker AJ; Stief CG
    Urol Res; 2007 Feb; 35(1):49-54. PubMed ID: 17102958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High lung PDE5: a strong basis for treating pulmonary hypertension with PDE5 inhibitors.
    Corbin JD; Beasley A; Blount MA; Francis SH
    Biochem Biophys Res Commun; 2005 Sep; 334(3):930-8. PubMed ID: 16023993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization.
    Blount MA; Zoraghi R; Ke H; Bessay EP; Corbin JD; Francis SH
    Mol Pharmacol; 2006 Nov; 70(5):1822-31. PubMed ID: 16926278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and functional role of androgen-dependent PDE5 activity in the bladder.
    Filippi S; Morelli A; Sandner P; Fibbi B; Mancina R; Marini M; Gacci M; Vignozzi L; Vannelli GB; Carini M; Forti G; Maggi M
    Endocrinology; 2007 Mar; 148(3):1019-29. PubMed ID: 17138653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel functions of cGMP-specific phosphodiesterase 5 and its inhibitors in carcinoma cells and pulmonary/cardiovascular vessels.
    Zhu B; Strada SJ
    Curr Top Med Chem; 2007; 7(4):437-54. PubMed ID: 17305584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery.
    Pauvert O; Lugnier C; Keravis T; Marthan R; Rousseau E; Savineau JP
    Br J Pharmacol; 2003 Jun; 139(3):513-22. PubMed ID: 12788811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    Murray F; MacLean MR; Pyne NJ
    Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries: activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway.
    Moreno L; Losada B; Cogolludo Al; Lodi F; Lugnier C; Villamor E; Moro M; Tamargo J; Pérez-Vizcaíno F
    Pediatr Res; 2004 Oct; 56(4):563-70. PubMed ID: 15295092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil, a PDE5 inhibitor, in the treatment of pulmonary hypertension.
    Hemnes AR; Champion HC
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):293-300. PubMed ID: 16716091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of phosphodiesterase-5 inhibitors in cardiopulmonary diseases: from experimental evidence to clinical application].
    Guazzi M; Vicenzi M; Samaja M
    G Ital Cardiol (Rome); 2009; 10(11-12):725-37. PubMed ID: 20101899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine-612 in PDE5 contributes to higher affinity for vardenafil over sildenafil.
    Corbin J; Francis S; Zoraghi R
    Int J Impot Res; 2006; 18(3):251-7. PubMed ID: 16281046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and effects of methyl-2- (4-aminophenyl)-1, 2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4, 5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (PDE5).
    Kotera J; Fujishige K; Michibata H; Yuasa K; Kubo A; Nakamura Y; Omori K
    Biochem Pharmacol; 2000 Nov; 60(9):1333-41. PubMed ID: 11008127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects.
    Kulkarni SK; Patil CS
    Methods Find Exp Clin Pharmacol; 2004 Dec; 26(10):789-99. PubMed ID: 15672122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific cGMP binding by the cGMP binding domains of cGMP-binding cGMP specific phosphodiesterase.
    Liu L; Underwood T; Li H; Pamukcu R; Thompson WJ
    Cell Signal; 2002 Jan; 14(1):45-51. PubMed ID: 11747988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New achievement and novel therapeutic applications of PDE5 inhibithors in older males.
    Frajese GV; Pozzi F
    J Endocrinol Invest; 2005; 28(3 Suppl):45-50. PubMed ID: 16042360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
    Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH
    Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells.
    Rybalkin SD; Rybalkina IG; Feil R; Hofmann F; Beavo JA
    J Biol Chem; 2002 Feb; 277(5):3310-7. PubMed ID: 11723116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.